RTS/S, R21 and now hopefully RH5 not too far behind. Promising results of Phase 2b trial in Burkina Faso especially in high density infections. But unknown longevity https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00752-7/fulltext

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service